Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Audited financial results for the Quarter and year ended 31st March, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 22nd May, 2026.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Limited has published its audited financial results for Q4 and full year ended March 31, 2026, in newspapers as required under SEBI regulations. For FY26, revenue from operations stood at Rs 771.66 crore, up from Rs 661.51 crore in FY25, showing approximately 17% revenue growth. However, profit after tax declined to Rs 41.05 crore from Rs 47.35 crore in the previous year, representing about 13% decline. Q4 FY26 PAT was Rs 11.68 crore versus Rs 12.46 crore in Q4 FY25. Earnings per share for FY26 was Rs 4.10 compared to Rs 4.72 in FY25.
While the company achieved revenue growth, the significant decline in profitability is a concern for shareholders. The stock may face downward pressure as earnings have contracted despite higher sales.